Cite

HARVARD Citation

    Chen, I. et al. (2021). Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation. Medicine. 100 (23), p. . [Online]. 
  
Back to record